Keywords: Well-Differentiated fetal adenocarcinoma; β-catenin; CTNNB1; BRCA2; TSC2; NGS;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: aHR; adjusted HR; BRCA2; breast cancer 2, early onset; CIs; confidence intervals; DFS; disease-free survival; ENCODE; encyclopedia of DNA Elements; ERCC1; excision repair cross-complementing group 1; ERG; V-ets avian erythroblastosis virus E26 oncogene re
Keywords: Breast cancer; BRCA1; BRCA2; Tamoxifen; Anastrazole; Oophorectomy; Chemoprevention;
Keywords: Formaldehyde; ADH5; FANCD2; Fanconi Anemia; SPRTN; BRCA1; BRCA2; Folate cycle; Ruijs-Aalfs syndrome;
Keywords: Breast cancer; BRCA1; BRCA2; Genetic counseling; Genetic testing;
Keywords: Genetic counseling; Genetic testing; Ovarian cancer; PARP inhibitors; BRCA1; BRCA2;
Keywords: Cáncer de mama; factores de riesgo; diagnóstico; BRCA1; BRCA2; Breast cancer; risk factors; diagnosis; BRCA 1; BRCA 2;
Keywords: BRCA2; Circulating tumor DNA; Cell-free DNA; Liquid biopsy; Enzalutamide; Abiraterone; Castration-resistant prostate cancer; DNA repair;
Keywords: BRCA1; BRCA2; Lynch syndrome; ovarian cancer; uterine cancer; high-throughput DNA sequencing;
Keywords: Male breast cancer; Epidemiology; Risk factors; Breast cancer; BRCA2; BRCA1; Management;
Keywords: hereditary ovarian cancer; risk-reducing salpingo-oophorectomy; BRCA1; BRCA2;
Keywords: ALK; anaplastic lymphoma receptor tyrosine kinase; ABCB1; ATP-binding cassette, sub-family B (MDR/TAP), member 1; APE1; apurinic/apyimidinic endonuclease 1; AKT; v-akt murine thymoma viral oncogene; BER; base excision repair; BRCA1; breast cancer 1; BRCA2
Keywords: APC; BRCA1; BRCA2; breast cancer; familial polyposis; oncogene; tumour suppressor gene
Keywords: Fanconi anemia; BRIP1; BRCA2; PALB2; FANCC; FANCG
Keywords: Risk-reducing salpingo-oophorectomy; Prophylactic oophorectomy; Female sexual function; Androgen levels; BRCA1; BRCA2; Lynch syndrome; Ovarian cancer; Female sexual dysfunction; Hypoactive sexual desire disorder; Breast cancer
Keywords: LS; Lynch syndrome; CRC; colorectal cancer; HNPCC; hereditary non-polyposis colon cancer; MMR; mismatch repair; FAP; familial adenomatous polyposis; CFS; cancer family syndrome; MSI; microsatellite instability; IDL; insertion/deletion loop; MSH2; human mu
Keywords: Breast cancer in men; Estrogen receptor; BRCA2; Androgen receptor; Tamoxifen;
Keywords: PARP inhibitors; DNA repair; Homologous recombination repair; HRD; Homologous recombination deficiency; BRCA1; BRCA2; Ovarian cancer; Olaparib;
Keywords: Hereditary cancer; BRCA1; BRCA2; Lynch syndrome; Ovarian carcinoma; Mismatch repair
Keywords: Cancer genomes; chromothripsis; kataegis; mutation signature; homologous recombination; BRCA1; BRCA2;
Keywords: High-grade serous ovarian cancer; Platinum; Chemotherapy; Resistance; p53; BRCA1; BRCA2; PARP inhibitors; Patient-derived xenografts
Keywords: Ovarian cancer; Surgical debulking; Chemotherapy; BRCA1; BRCA2; Bevacizumab; PARP inhibitors; Immunotherapy;
Keywords: Pancreatic cancer; Genetic testing; BRCA2; CDKN2A;
Keywords: Hereditary cancer; BRCA1; BRCA2; Lynch syndrome; Cowden syndrome; Genetic testing;
Keywords: Serous ovarian cancer; BRCA1; BRCA2; Genetic testing; Genetic counseling
Keywords: Serous ovarian cancer; Platinum; Xenograft; DNA repair; BRCA1; BRCA2; MLPA; multiplex ligation-dependent probe amplification; PFA; paraformaldehyde; FCS; fetal calf serum; FFPE; Formalin Fixed Paraffin Embedded; PBS; phosphate buffered saline; d; day;
Keywords: Ovarian cancer; Serous; BRCA1; BRCA2; Genetic testing; Genetic counseling;
Keywords: Hereditary breast cancer; BRCA1; BRCA2; Counseling;
Keywords: Fanconi anaemia; BRCA2; Glioblastoma multiforme
Keywords: Mastectomy; Prophylactic surgical procedures; Counseling; BRCA1; BRCA2; Shared decision making
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation
Keywords: Ovarian cancer; BRCA1; BRCA2; Age-specific risk;
Prediction of DNA methylation in the promoter of gene suppressor tumor
Keywords: DNA; deoxyribonucleic acid; CpG; cytosine-phosphate-guanine; HMM; hidden Markov model; DNMTs; DNA méthyltransférase; CGI; CpG islands; bp; base pair; BRCA1; breast cancer 1; BRCA2; breast cancer 2; CHEK2; Checkpoint kinase 2; P53; tumor protein 53; PTEN
Collaboration in the actions of Brh2 with resolving functions during DNA repair and replication stress in Ustilago maydis
Keywords: HR; homologous recombination; HU; hydroxyurea; MMS; methyl methanesulfonate; UV; ultraviolet light; BRCA2; Blm; Mus81; Gen1; DNA repair; Replication stress;
Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA
Keywords: A-EJ; alternative end joing; APH; aphidicolin; BIR; break induced replication; BTRR; BLM helicase/topoisomerase IIIa (TOPOIIIa)/RMI1 and RMI2 cofactors; CFS; common fragile sites; Cis; cisplatin; DEB; diepoxybutane; DSBs; double strand breaks; DSEs; one e
Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancer
Keywords: BRCA1; BRCA2; Breast cancer; Decision aid; Decision support; Treatment-focused genetic testing;
Downregulation of PARP1 transcription by CDK4/6 inhibitors sensitizes human lung cancer cells to anticancer drug-induced death by impairing OGG1-dependent base excision repair
Keywords: CDK4/6; cyclin-dependent kinases 4 and 6; CDK2; cyclin-dependent kinase 2; iCDK4/6; inhibitor of CDK4/6; LEE011; inhibitor of CDK4/6, ribociclib, Kisqali; PD0332991; inhibitor of CDK4/6, palbociclib, Imbrance; NU6140; cyclin-dependent kinase 2 (CDK2) inhi
BRCA1 Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial Cells
Keywords: ACHP; 2-amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-(4-piperidinyl)-3-pyridinecarbonitrile; BRCA1; breast cancer 1, early onset; BRCA2; breast cancer 2, early onset; EGFR; epidermal growth factor receptor; FBS; fetal bovine serum; FDR; false discov
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer
Keywords: BRCA1; breast cancer susceptibility gene 1; BRCA2; breast cancer susceptibility gene 2; CCOC; clear cell ovarian carcinoma; DAB; 3,3â²-diaminobenzidine; ENOC; endometrioid ovarian carcinoma; EOC; epithelial ovarian cancer; HGSOC; high-grade serous ovaria
Association of BRCA2 variants with breast cancer risk: A meta-analysis
Keywords: Breast cancer; Meta-analysis; BRCA2;
DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223
Keywords: Alkaline phosphatase; Biomarker; BRCA2; CHEK2; Genetic sequencing;
BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers
Keywords: BRCA1; BRCA2; Cancer; Digestive system; Immunohistochemistry;
Phytoestrogens and mycoestrogens interacting with breast cancer proteins
Keywords: AUC; area under the curve; BRCA1; breast cancer 1; BRCA2; breast cancer 2, CAT, catalase; DHT; dihydrotestosterone; EDCs; endocrine disrupting chemicals; ERBB2; human epidermal growth factor receptor 2; ERBBs; epidermal growth factor receptor family; ER-b
BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma
Keywords: BRCA1; breast cancer 1; BRCA2; breast cancer 2; DFS; disease-free survival; HR; hazard ratio; NGS; next-generation sequencing; OS; overall survival; PDAC; pancreatic ductal adenocarcinoma; VUS; variants of unknown significance; WT; BRCA1/BRCA2 wild-type;
Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center
Keywords: BRCA1; BRCA2; Next Generation Sequencing (NGS); Multiplex Ligation-dependent Probe Amplification (MLPA); Greece;
The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential
Keywords: APC/C; anaphase-promoting complex/cyclosome; ASF1; antisilencing function 1; BRAF35; BRCA2-associated factor 35; BRCA2; breast cancer 2 protein; CAF-1; chromatin assembly factor 1; CR; cysteine rich; DCIS; ductal carcinoma in situ; DNMT3B; DNA methyltrans
Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits
Keywords: BRCA1; BRCA2; Methylation; Loss of heterozygosity; Tumor cell percentage;
The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
Keywords: ABCB1; ATP-binding cassette sub-family B member 1; AML; acute myeloid leukaemia; AMPK; adenosine monophosphate-activated protein kinase; ATM; Ataxia-telangiectasia mutated; AURKA; aurora kinase A; BER; base excision repair; Bim; B-cell lymphoma 2 interact
Ampullary carcinoma-A genetic perspective
Keywords: AVC; ampulla of vater carcinoma; KRAS; Kirsten rat sarcoma viral oncogene homolog; OS; overall survival; RFS; recurrence free survival; HER2; human epidermal growth factor receptor 2; BRAF; B rapidly activated fibrosarcoma; BRCA2; breast cancer 2; TP53; t
Discusión ética y legal del asesoramiento genético en paciente portadora de una variación patológica en RAD51D
Keywords: RAD51D; Cáncer hereditario de mama; Cáncer hereditario de ovario; BRCA1; BRCA2; Asesoramiento genético; Aspectos ético-legales; RAD51D; Hereditary breast cancer; Hereditary ovarian cancer; BRCA1; BRCA2; Genetic counselling; Ethical-legal aspects;
Cancer de la prostate et gènes de réparation de l'ADN
Keywords: BRCA2; BRCA1; Dépistage ciblé; Inhibiteur de PARP; Sur-incidence; BRCA1; BRCA2; Specific screening; PARP inhibitor; Over-incidence;